Merck, Serum partner to develop pneumococcal conjugate vaccine
Merck and Serum Institute of India have joined hands to develop and commercialize pneumococcal conjugate vaccine for the developing nations.
The currently available pneumococcal vaccines are effective in preventing invasive pneumococcal disease, according to a study in the Medical Journal of Australia.